← Eichor
Study identifier: NCT07421882 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

PRE-hospital Cooling to improvE carDiac arrEst Neurological outComEs (PRECEDENCE)

Condition: Out-Of-Hospital Cardiac Arrest · Cardiopulmonary Resuscitation · Death, Sudden, Cardiac  ·  Sponsor: Singapore General Hospital

PhaseNA
Planned participants50
Who can joinAll sexes, 16 Years to 80 Years
Healthy volunteersNo

About this study

The PRE-hospital Cooling to improvE carDiac arrEst Neurological outComEs (PRECEDENCE) study is a pilot feasibility trial evaluating the implementation of pre-hospital targeted temperature management (TTM) using a wearable surface cooling device (CarbonCool® vest) in adult out-of-hospital cardiac arrest (OHCA) patients with return of spontaneous circulation (ROSC). The study aims to assess feasibility, fidelity, acceptability, and safety of initiating cooling in the field by emergency medical services (EMS) prior to hospital arrival. Results will inform the design of a larger definitive trial to determine the clinical effectiveness of early pre-hospital TTM in improving neurological outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

Shir Lynn Lim, MBBS  ·  +65 91760383  ·  shir.lynn.lim@nus.edu.sg

Always discuss trial participation with your own doctor first.

Locations (1)

National University Heart Centre, Singapore (NUHCS)Singapore, SingaporeRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07421882